Viewing SEC Facts Units
Company Name:
Taysha Gene Therapies, Inc.
CIK:
1806310
Start Filing Date:
2023-01-01
End Filing Date:
2023-12-31
ACCN:
0000950170-24-033484
Value:
$ 7,800,000
Value Error:
$ None
Created By:
Date Filed:
2024-03-19
FY:
2023
Fiscal Period:
FY
Frame:
CY2023
Type:
us-gaap
Form:
10-K
Units:
USD